Numerically, there was a 210-fold expansion of SPAS-1 specific CD8+ T cells after tumor challenge yielding an average of 7832 CD8+ T cells in the lymphoid organs of a single mouse (Fig. 1e). This evidence concerns the gene CD8A and neoplasm.